IL-6 promotes metastatic colonization of CRC cells by modulating the tumor immune microenvironment, and in primary tumors, CRC patients with low IL-6 expression exhibit prolonged disease-free survival (Toyoshima, et al., 2019). The gene discussed is IL6; the disease is colorectal carcinoma.